Table 1.
HCV RNA Viral Loads in Human Brain Tissue
| Sample ID |
Age (y) |
Sex | HIV status |
HCV status |
Liver pathology | Cause of death | Postmortem interval (h) |
HCV RNA load (10 mg tissue) |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liver | Cerebral grey matter |
Cerebral white matter |
Cerebellum | Medulla | ||||||||
| 10034 | 49 | Male | Positive | Positive | Cirrhosis | Pneumonia | 4.5 | 6.1 × 108 | 3.8 × 104 | 5.4 × 103 | 4.7 × 103 | 6.4 × 103 |
| 10066 | 54 | Female | Positive | Positive | Cirrhosis | Probable sepsis | 7 | 1.8 × 108 | — | 1.7 × 102 | — | — |
| 20024 | 62 | Male | Positive | Positive | Fibrosis | Bronchiolitis, emphysema, aortic stenosis |
4 | 9.4 × 108 | 1.1 × 105 | — | — | — |
| 40007 | 53 | Male | Negative | Positive | Cirrhosis | End-stage liver disease | 11.5 | 9.0 × 106 | 4.0 × 102 | 8.5 × 102 | — | — |
| 10016 | 58 | Female | Positive | Positive | Cirrhosis | Extensive metastatic calcifications and congestive heart failure |
17 | 4.2 × 108 | — | — | — | — |
| 10027 | 39 | Male | Positive | Positive | Cirrhosis | Severe cachexia, HIV encephalitis |
4 | 1.4 × 109 | — | — | — | — |
| 10086 | 48 | Female | Positive | Positive | Cirrhosis | Pneumonia and sepsis | 7.5 | 1.1 × 109 | — | — | — | — |
| 20028 | 49 | Male | Positive | Positive | Cirrhosis | Cardiac and liver failure | 6 | 4.7 × 108 | — | — | — | — |
| 40003 | 54 | Male | Negative | Positive | Cirrhosis | Sepsis, pneumonitis, end- stage liver disease, and renal failure |
14.5 | 3.1 × 108 | — | — | ND | ND |
| 537 | 44 | Male | Negative | Positive | Minimal steatosis, fibrosis, and inflammation |
Pneumonia (Pneumocystis carinii, cytomegalovirus) |
27 | 1.9 × 109 | — | — | ND | ND |
NOTE. HCV RNA from matched brain and liver tissue from HCV-positive clinical samples was quantified by qRT-PCR and normalized to GAPDH. Virus was detected in the liver of all 10 subjects and in the brain tissue of 4 subjects. Viral load was approximately 1000-fold lower in the brain compared with the liver. HCV E1 sequence variation between liver and plasma was previously reported for samples 10034, 20024, 20028, and 40007.29
ND, not determined.